nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—SLC46A1—Sulfasalazine—ankylosing spondylitis	0.159	0.529	CbGbCtD
Methotrexate—psoriatic arthritis—ankylosing spondylitis	0.15	0.243	CtDrD
Methotrexate—systemic scleroderma—ankylosing spondylitis	0.144	0.235	CtDrD
Methotrexate—systemic lupus erythematosus—ankylosing spondylitis	0.118	0.191	CtDrD
Methotrexate—rheumatoid arthritis—ankylosing spondylitis	0.111	0.18	CtDrD
Methotrexate—psoriasis—ankylosing spondylitis	0.0931	0.151	CtDrD
Methotrexate—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.019	0.0632	CbGbCtD
Methotrexate—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0171	0.0567	CbGbCtD
Methotrexate—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0167	0.0555	CbGbCtD
Methotrexate—SLCO1A2—Prednisone—ankylosing spondylitis	0.0161	0.0535	CbGbCtD
Methotrexate—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0151	0.0502	CbGbCtD
Methotrexate—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.0101	0.0334	CbGbCtD
Methotrexate—ABCC2—Dexamethasone—ankylosing spondylitis	0.00834	0.0277	CbGbCtD
Methotrexate—ALB—Prednisone—ankylosing spondylitis	0.00832	0.0277	CbGbCtD
Methotrexate—ABCG2—Dexamethasone—ankylosing spondylitis	0.00754	0.025	CbGbCtD
Methotrexate—ABCB1—Methylprednisolone—ankylosing spondylitis	0.00719	0.0239	CbGbCtD
Methotrexate—ABCB1—Betamethasone—ankylosing spondylitis	0.00467	0.0155	CbGbCtD
Methotrexate—ABCB1—Prednisolone—ankylosing spondylitis	0.00461	0.0153	CbGbCtD
Methotrexate—ABCB1—Prednisone—ankylosing spondylitis	0.00435	0.0145	CbGbCtD
Methotrexate—ABCB1—Dexamethasone—ankylosing spondylitis	0.00272	0.00903	CbGbCtD
Methotrexate—Conjunctivitis—Prednisolone—ankylosing spondylitis	9.11e-05	0.00112	CcSEcCtD
Methotrexate—Lethargy—Prednisone—ankylosing spondylitis	9.02e-05	0.00111	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	8.98e-05	0.00111	CcSEcCtD
Methotrexate—Osteoarthritis—Prednisone—ankylosing spondylitis	8.84e-05	0.00109	CcSEcCtD
Methotrexate—Infestation NOS—Methylprednisolone—ankylosing spondylitis	8.6e-05	0.00106	CcSEcCtD
Methotrexate—Infestation—Methylprednisolone—ankylosing spondylitis	8.6e-05	0.00106	CcSEcCtD
Methotrexate—Haemoglobin—Prednisolone—ankylosing spondylitis	8.45e-05	0.00104	CcSEcCtD
Methotrexate—Irritability—Prednisone—ankylosing spondylitis	8.43e-05	0.00104	CcSEcCtD
Methotrexate—Haemorrhage—Prednisolone—ankylosing spondylitis	8.41e-05	0.00104	CcSEcCtD
Methotrexate—Conjunctivitis—Triamcinolone—ankylosing spondylitis	8.38e-05	0.00103	CcSEcCtD
Methotrexate—Mood swings—Prednisone—ankylosing spondylitis	8.37e-05	0.00103	CcSEcCtD
Methotrexate—Sweating—Methylprednisolone—ankylosing spondylitis	8.24e-05	0.00102	CcSEcCtD
Methotrexate—Epistaxis—Triamcinolone—ankylosing spondylitis	8.13e-05	0.001	CcSEcCtD
Methotrexate—Visual impairment—Prednisolone—ankylosing spondylitis	8.11e-05	0.000999	CcSEcCtD
Methotrexate—Haemoglobin—Triamcinolone—ankylosing spondylitis	7.78e-05	0.000958	CcSEcCtD
Methotrexate—Haemoglobin—Methylprednisolone—ankylosing spondylitis	7.76e-05	0.000956	CcSEcCtD
Methotrexate—Haemorrhage—Triamcinolone—ankylosing spondylitis	7.74e-05	0.000953	CcSEcCtD
Methotrexate—Haemorrhage—Methylprednisolone—ankylosing spondylitis	7.72e-05	0.000951	CcSEcCtD
Methotrexate—Pharyngitis—Triamcinolone—ankylosing spondylitis	7.68e-05	0.000946	CcSEcCtD
Methotrexate—Conjunctivitis—Betamethasone—ankylosing spondylitis	7.6e-05	0.000937	CcSEcCtD
Methotrexate—Conjunctivitis—Dexamethasone—ankylosing spondylitis	7.6e-05	0.000937	CcSEcCtD
Methotrexate—Pancreatitis—Prednisone—ankylosing spondylitis	7.49e-05	0.000923	CcSEcCtD
Methotrexate—Visual impairment—Methylprednisolone—ankylosing spondylitis	7.44e-05	0.000917	CcSEcCtD
Methotrexate—Erythema—Prednisolone—ankylosing spondylitis	7.32e-05	0.000903	CcSEcCtD
Methotrexate—Eye disorder—Methylprednisolone—ankylosing spondylitis	7.21e-05	0.000889	CcSEcCtD
Methotrexate—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	7.16e-05	0.000883	CcSEcCtD
Methotrexate—Neutropenia—Prednisone—ankylosing spondylitis	7.14e-05	0.00088	CcSEcCtD
Methotrexate—Haemoglobin—Dexamethasone—ankylosing spondylitis	7.05e-05	0.00087	CcSEcCtD
Methotrexate—Haemoglobin—Betamethasone—ankylosing spondylitis	7.05e-05	0.00087	CcSEcCtD
Methotrexate—Erectile dysfunction—Prednisone—ankylosing spondylitis	7.03e-05	0.000867	CcSEcCtD
Methotrexate—Haemorrhage—Dexamethasone—ankylosing spondylitis	7.02e-05	0.000865	CcSEcCtD
Methotrexate—Haemorrhage—Betamethasone—ankylosing spondylitis	7.02e-05	0.000865	CcSEcCtD
Methotrexate—Angiopathy—Methylprednisolone—ankylosing spondylitis	7e-05	0.000863	CcSEcCtD
Methotrexate—Immune system disorder—Methylprednisolone—ankylosing spondylitis	6.97e-05	0.000859	CcSEcCtD
Methotrexate—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	6.96e-05	0.000857	CcSEcCtD
Methotrexate—Vision blurred—Prednisolone—ankylosing spondylitis	6.9e-05	0.000851	CcSEcCtD
Methotrexate—Ill-defined disorder—Prednisolone—ankylosing spondylitis	6.79e-05	0.000837	CcSEcCtD
Methotrexate—Depression—Prednisone—ankylosing spondylitis	6.79e-05	0.000837	CcSEcCtD
Methotrexate—Visual impairment—Betamethasone—ankylosing spondylitis	6.76e-05	0.000834	CcSEcCtD
Methotrexate—Visual impairment—Dexamethasone—ankylosing spondylitis	6.76e-05	0.000834	CcSEcCtD
Methotrexate—Mental disorder—Methylprednisolone—ankylosing spondylitis	6.76e-05	0.000833	CcSEcCtD
Methotrexate—Erythema—Triamcinolone—ankylosing spondylitis	6.73e-05	0.00083	CcSEcCtD
Methotrexate—Malnutrition—Methylprednisolone—ankylosing spondylitis	6.72e-05	0.000828	CcSEcCtD
Methotrexate—Erythema—Methylprednisolone—ankylosing spondylitis	6.72e-05	0.000828	CcSEcCtD
Methotrexate—Malaise—Prednisolone—ankylosing spondylitis	6.6e-05	0.000814	CcSEcCtD
Methotrexate—Dysgeusia—Triamcinolone—ankylosing spondylitis	6.59e-05	0.000813	CcSEcCtD
Methotrexate—Vertigo—Prednisolone—ankylosing spondylitis	6.58e-05	0.000811	CcSEcCtD
Methotrexate—Eye disorder—Betamethasone—ankylosing spondylitis	6.56e-05	0.000808	CcSEcCtD
Methotrexate—Eye disorder—Dexamethasone—ankylosing spondylitis	6.56e-05	0.000808	CcSEcCtD
Methotrexate—Back pain—Triamcinolone—ankylosing spondylitis	6.51e-05	0.000803	CcSEcCtD
Methotrexate—Angiopathy—Betamethasone—ankylosing spondylitis	6.37e-05	0.000785	CcSEcCtD
Methotrexate—Angiopathy—Dexamethasone—ankylosing spondylitis	6.37e-05	0.000785	CcSEcCtD
Methotrexate—Convulsion—Prednisolone—ankylosing spondylitis	6.34e-05	0.000782	CcSEcCtD
Methotrexate—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	6.25e-05	0.00077	CcSEcCtD
Methotrexate—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	6.23e-05	0.000768	CcSEcCtD
Methotrexate—Alopecia—Dexamethasone—ankylosing spondylitis	6.2e-05	0.000764	CcSEcCtD
Methotrexate—Alopecia—Betamethasone—ankylosing spondylitis	6.2e-05	0.000764	CcSEcCtD
Methotrexate—Discomfort—Prednisolone—ankylosing spondylitis	6.16e-05	0.000759	CcSEcCtD
Methotrexate—Haemoglobin—Prednisone—ankylosing spondylitis	6.14e-05	0.000757	CcSEcCtD
Methotrexate—Haemorrhage—Prednisone—ankylosing spondylitis	6.11e-05	0.000753	CcSEcCtD
Methotrexate—Erythema—Betamethasone—ankylosing spondylitis	6.11e-05	0.000753	CcSEcCtD
Methotrexate—Erythema—Dexamethasone—ankylosing spondylitis	6.11e-05	0.000753	CcSEcCtD
Methotrexate—Malaise—Triamcinolone—ankylosing spondylitis	6.07e-05	0.000748	CcSEcCtD
Methotrexate—Malaise—Methylprednisolone—ankylosing spondylitis	6.06e-05	0.000747	CcSEcCtD
Methotrexate—Vertigo—Triamcinolone—ankylosing spondylitis	6.05e-05	0.000746	CcSEcCtD
Methotrexate—Vertigo—Methylprednisolone—ankylosing spondylitis	6.04e-05	0.000744	CcSEcCtD
Methotrexate—Anaphylactic shock—Prednisolone—ankylosing spondylitis	5.98e-05	0.000737	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Methylprednisolone—ankylosing spondylitis	5.9e-05	0.0331	CbGdCrCtD
Methotrexate—Cough—Triamcinolone—ankylosing spondylitis	5.88e-05	0.000724	CcSEcCtD
Methotrexate—Convulsion—Triamcinolone—ankylosing spondylitis	5.83e-05	0.000719	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Methylprednisolone—ankylosing spondylitis	5.83e-05	0.0327	CbGdCrCtD
Methotrexate—Convulsion—Methylprednisolone—ankylosing spondylitis	5.82e-05	0.000718	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Dexamethasone—ankylosing spondylitis	5.81e-05	0.0326	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Betamethasone—ankylosing spondylitis	5.81e-05	0.0326	CbGdCrCtD
Methotrexate—Hyperhidrosis—Prednisolone—ankylosing spondylitis	5.78e-05	0.000712	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Methylprednisolone—ankylosing spondylitis	5.77e-05	0.0324	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Dexamethasone—ankylosing spondylitis	5.74e-05	0.0322	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Betamethasone—ankylosing spondylitis	5.74e-05	0.0322	CbGdCrCtD
Methotrexate—Myalgia—Triamcinolone—ankylosing spondylitis	5.73e-05	0.000707	CcSEcCtD
Methotrexate—Arthralgia—Methylprednisolone—ankylosing spondylitis	5.72e-05	0.000705	CcSEcCtD
Methotrexate—Myalgia—Methylprednisolone—ankylosing spondylitis	5.72e-05	0.000705	CcSEcCtD
Methotrexate—Eye disorder—Prednisone—ankylosing spondylitis	5.71e-05	0.000704	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	5.68e-05	0.0007	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Triamcinolone—ankylosing spondylitis	5.68e-05	0.0319	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Dexamethasone—ankylosing spondylitis	5.68e-05	0.0319	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Betamethasone—ankylosing spondylitis	5.68e-05	0.0319	CbGdCrCtD
Methotrexate—Ill-defined disorder—Betamethasone—ankylosing spondylitis	5.67e-05	0.000699	CcSEcCtD
Methotrexate—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	5.67e-05	0.000699	CcSEcCtD
Methotrexate—Discomfort—Triamcinolone—ankylosing spondylitis	5.66e-05	0.000698	CcSEcCtD
Methotrexate—Discomfort—Methylprednisolone—ankylosing spondylitis	5.65e-05	0.000697	CcSEcCtD
Methotrexate—TYMS—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	5.62e-05	0.0316	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Triamcinolone—ankylosing spondylitis	5.6e-05	0.0315	CbGdCrCtD
Methotrexate—Angiopathy—Prednisone—ankylosing spondylitis	5.55e-05	0.000684	CcSEcCtD
Methotrexate—TYMS—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	5.54e-05	0.0311	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	5.54e-05	0.0311	CbGdCrCtD
Methotrexate—Confusional state—Methylprednisolone—ankylosing spondylitis	5.53e-05	0.000682	CcSEcCtD
Methotrexate—Immune system disorder—Prednisone—ankylosing spondylitis	5.52e-05	0.000681	CcSEcCtD
Methotrexate—Malaise—Dexamethasone—ankylosing spondylitis	5.51e-05	0.000679	CcSEcCtD
Methotrexate—Malaise—Betamethasone—ankylosing spondylitis	5.51e-05	0.000679	CcSEcCtD
Methotrexate—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	5.5e-05	0.000677	CcSEcCtD
Methotrexate—Vertigo—Dexamethasone—ankylosing spondylitis	5.49e-05	0.000677	CcSEcCtD
Methotrexate—Vertigo—Betamethasone—ankylosing spondylitis	5.49e-05	0.000677	CcSEcCtD
Methotrexate—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	5.48e-05	0.000676	CcSEcCtD
Methotrexate—Infection—Triamcinolone—ankylosing spondylitis	5.46e-05	0.000673	CcSEcCtD
Methotrexate—Infection—Methylprednisolone—ankylosing spondylitis	5.45e-05	0.000671	CcSEcCtD
Methotrexate—TYMS—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	5.41e-05	0.0304	CbGdCrCtD
Methotrexate—Insomnia—Prednisolone—ankylosing spondylitis	5.41e-05	0.000666	CcSEcCtD
Methotrexate—Alopecia—Prednisone—ankylosing spondylitis	5.4e-05	0.000666	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisone—ankylosing spondylitis	5.39e-05	0.0303	CbGdCrCtD
Methotrexate—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	5.38e-05	0.000663	CcSEcCtD
Methotrexate—Paraesthesia—Prednisolone—ankylosing spondylitis	5.37e-05	0.000661	CcSEcCtD
Methotrexate—Mental disorder—Prednisone—ankylosing spondylitis	5.36e-05	0.00066	CcSEcCtD
Methotrexate—Skin disorder—Methylprednisolone—ankylosing spondylitis	5.33e-05	0.000657	CcSEcCtD
Methotrexate—Malnutrition—Prednisone—ankylosing spondylitis	5.32e-05	0.000656	CcSEcCtD
Methotrexate—Erythema—Prednisone—ankylosing spondylitis	5.32e-05	0.000656	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Prednisone—ankylosing spondylitis	5.32e-05	0.0299	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Methylprednisolone—ankylosing spondylitis	5.32e-05	0.0298	CbGdCrCtD
Methotrexate—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	5.31e-05	0.000655	CcSEcCtD
Methotrexate—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	5.3e-05	0.000653	CcSEcCtD
Methotrexate—Convulsion—Betamethasone—ankylosing spondylitis	5.29e-05	0.000653	CcSEcCtD
Methotrexate—Convulsion—Dexamethasone—ankylosing spondylitis	5.29e-05	0.000653	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Prednisone—ankylosing spondylitis	5.26e-05	0.0296	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisolone—ankylosing spondylitis	5.26e-05	0.0295	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Betamethasone—ankylosing spondylitis	5.23e-05	0.0294	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Dexamethasone—ankylosing spondylitis	5.23e-05	0.0294	CbGdCrCtD
Methotrexate—Myalgia—Dexamethasone—ankylosing spondylitis	5.2e-05	0.000641	CcSEcCtD
Methotrexate—Myalgia—Betamethasone—ankylosing spondylitis	5.2e-05	0.000641	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Prednisolone—ankylosing spondylitis	5.19e-05	0.0291	CbGdCrCtD
Methotrexate—Discomfort—Betamethasone—ankylosing spondylitis	5.14e-05	0.000633	CcSEcCtD
Methotrexate—Discomfort—Dexamethasone—ankylosing spondylitis	5.14e-05	0.000633	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Prednisolone—ankylosing spondylitis	5.14e-05	0.0288	CbGdCrCtD
Methotrexate—Hypotension—Methylprednisolone—ankylosing spondylitis	5.12e-05	0.000632	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Triamcinolone—ankylosing spondylitis	5.11e-05	0.0287	CbGdCrCtD
Methotrexate—Pain—Prednisolone—ankylosing spondylitis	5.11e-05	0.00063	CcSEcCtD
Methotrexate—Vision blurred—Prednisone—ankylosing spondylitis	5.02e-05	0.000618	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	5.01e-05	0.000617	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	5e-05	0.000616	CcSEcCtD
Methotrexate—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	4.99e-05	0.000615	CcSEcCtD
Methotrexate—Anaphylactic shock—Betamethasone—ankylosing spondylitis	4.99e-05	0.000615	CcSEcCtD
Methotrexate—Insomnia—Triamcinolone—ankylosing spondylitis	4.97e-05	0.000613	CcSEcCtD
Methotrexate—Insomnia—Methylprednisolone—ankylosing spondylitis	4.96e-05	0.000611	CcSEcCtD
Methotrexate—Infection—Betamethasone—ankylosing spondylitis	4.95e-05	0.000611	CcSEcCtD
Methotrexate—Infection—Dexamethasone—ankylosing spondylitis	4.95e-05	0.000611	CcSEcCtD
Methotrexate—Ill-defined disorder—Prednisone—ankylosing spondylitis	4.94e-05	0.000609	CcSEcCtD
Methotrexate—Paraesthesia—Triamcinolone—ankylosing spondylitis	4.94e-05	0.000608	CcSEcCtD
Methotrexate—Feeling abnormal—Prednisolone—ankylosing spondylitis	4.92e-05	0.000607	CcSEcCtD
Methotrexate—Paraesthesia—Methylprednisolone—ankylosing spondylitis	4.92e-05	0.000607	CcSEcCtD
Methotrexate—Anaemia—Prednisone—ankylosing spondylitis	4.92e-05	0.000606	CcSEcCtD
Methotrexate—Dyspnoea—Triamcinolone—ankylosing spondylitis	4.9e-05	0.000604	CcSEcCtD
Methotrexate—Nervous system disorder—Dexamethasone—ankylosing spondylitis	4.89e-05	0.000603	CcSEcCtD
Methotrexate—Nervous system disorder—Betamethasone—ankylosing spondylitis	4.89e-05	0.000603	CcSEcCtD
Methotrexate—Thrombocytopenia—Betamethasone—ankylosing spondylitis	4.88e-05	0.000602	CcSEcCtD
Methotrexate—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	4.88e-05	0.000602	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Prednisone—ankylosing spondylitis	4.85e-05	0.0272	CbGdCrCtD
Methotrexate—Dyspepsia—Triamcinolone—ankylosing spondylitis	4.84e-05	0.000596	CcSEcCtD
Methotrexate—Dyspepsia—Methylprednisolone—ankylosing spondylitis	4.83e-05	0.000595	CcSEcCtD
Methotrexate—Hyperhidrosis—Betamethasone—ankylosing spondylitis	4.82e-05	0.000594	CcSEcCtD
Methotrexate—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	4.82e-05	0.000594	CcSEcCtD
Methotrexate—Malaise—Prednisone—ankylosing spondylitis	4.8e-05	0.000591	CcSEcCtD
Methotrexate—Vertigo—Prednisone—ankylosing spondylitis	4.78e-05	0.000589	CcSEcCtD
Methotrexate—Anorexia—Betamethasone—ankylosing spondylitis	4.75e-05	0.000586	CcSEcCtD
Methotrexate—Anorexia—Dexamethasone—ankylosing spondylitis	4.75e-05	0.000586	CcSEcCtD
Methotrexate—Urticaria—Prednisolone—ankylosing spondylitis	4.75e-05	0.000585	CcSEcCtD
Methotrexate—Fatigue—Triamcinolone—ankylosing spondylitis	4.74e-05	0.000584	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Prednisolone—ankylosing spondylitis	4.74e-05	0.0266	CbGdCrCtD
Methotrexate—Fatigue—Methylprednisolone—ankylosing spondylitis	4.73e-05	0.000583	CcSEcCtD
Methotrexate—Pain—Triamcinolone—ankylosing spondylitis	4.7e-05	0.000579	CcSEcCtD
Methotrexate—TYMS—Budesonide—Methylprednisolone—ankylosing spondylitis	4.66e-05	0.0262	CbGdCrCtD
Methotrexate—Hypotension—Dexamethasone—ankylosing spondylitis	4.66e-05	0.000574	CcSEcCtD
Methotrexate—Hypotension—Betamethasone—ankylosing spondylitis	4.66e-05	0.000574	CcSEcCtD
Methotrexate—Convulsion—Prednisone—ankylosing spondylitis	4.61e-05	0.000568	CcSEcCtD
Methotrexate—TYMS—Budesonide—Betamethasone—ankylosing spondylitis	4.59e-05	0.0258	CbGdCrCtD
Methotrexate—TYMS—Budesonide—Dexamethasone—ankylosing spondylitis	4.59e-05	0.0258	CbGdCrCtD
Methotrexate—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	4.54e-05	0.00056	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	4.54e-05	0.00056	CcSEcCtD
Methotrexate—Arthralgia—Prednisone—ankylosing spondylitis	4.53e-05	0.000558	CcSEcCtD
Methotrexate—Myalgia—Prednisone—ankylosing spondylitis	4.53e-05	0.000558	CcSEcCtD
Methotrexate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	4.53e-05	0.000558	CcSEcCtD
Methotrexate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	4.52e-05	0.000557	CcSEcCtD
Methotrexate—Insomnia—Betamethasone—ankylosing spondylitis	4.51e-05	0.000556	CcSEcCtD
Methotrexate—Insomnia—Dexamethasone—ankylosing spondylitis	4.51e-05	0.000556	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	4.5e-05	0.000555	CcSEcCtD
Methotrexate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	4.48e-05	0.000553	CcSEcCtD
Methotrexate—TYMS—Budesonide—Triamcinolone—ankylosing spondylitis	4.48e-05	0.0252	CbGdCrCtD
Methotrexate—Paraesthesia—Dexamethasone—ankylosing spondylitis	4.48e-05	0.000552	CcSEcCtD
Methotrexate—Paraesthesia—Betamethasone—ankylosing spondylitis	4.48e-05	0.000552	CcSEcCtD
Methotrexate—Discomfort—Prednisone—ankylosing spondylitis	4.48e-05	0.000552	CcSEcCtD
Methotrexate—Hypersensitivity—Prednisolone—ankylosing spondylitis	4.4e-05	0.000543	CcSEcCtD
Methotrexate—Dyspepsia—Dexamethasone—ankylosing spondylitis	4.39e-05	0.000541	CcSEcCtD
Methotrexate—Dyspepsia—Betamethasone—ankylosing spondylitis	4.39e-05	0.000541	CcSEcCtD
Methotrexate—Urticaria—Triamcinolone—ankylosing spondylitis	4.37e-05	0.000538	CcSEcCtD
Methotrexate—Urticaria—Methylprednisolone—ankylosing spondylitis	4.36e-05	0.000537	CcSEcCtD
Methotrexate—Body temperature increased—Triamcinolone—ankylosing spondylitis	4.34e-05	0.000535	CcSEcCtD
Methotrexate—Anaphylactic shock—Prednisone—ankylosing spondylitis	4.34e-05	0.000535	CcSEcCtD
Methotrexate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	4.34e-05	0.000534	CcSEcCtD
Methotrexate—Decreased appetite—Dexamethasone—ankylosing spondylitis	4.34e-05	0.000534	CcSEcCtD
Methotrexate—Decreased appetite—Betamethasone—ankylosing spondylitis	4.34e-05	0.000534	CcSEcCtD
Methotrexate—Infection—Prednisone—ankylosing spondylitis	4.31e-05	0.000532	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	4.31e-05	0.000531	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	4.31e-05	0.000531	CcSEcCtD
Methotrexate—Fatigue—Dexamethasone—ankylosing spondylitis	4.3e-05	0.00053	CcSEcCtD
Methotrexate—Fatigue—Betamethasone—ankylosing spondylitis	4.3e-05	0.00053	CcSEcCtD
Methotrexate—Pain—Dexamethasone—ankylosing spondylitis	4.26e-05	0.000526	CcSEcCtD
Methotrexate—Pain—Betamethasone—ankylosing spondylitis	4.26e-05	0.000526	CcSEcCtD
Methotrexate—Nervous system disorder—Prednisone—ankylosing spondylitis	4.26e-05	0.000525	CcSEcCtD
Methotrexate—TYMS—Budesonide—Prednisone—ankylosing spondylitis	4.25e-05	0.0239	CbGdCrCtD
Methotrexate—Skin disorder—Prednisone—ankylosing spondylitis	4.22e-05	0.00052	CcSEcCtD
Methotrexate—Hyperhidrosis—Prednisone—ankylosing spondylitis	4.2e-05	0.000517	CcSEcCtD
Methotrexate—TYMS—Budesonide—Prednisolone—ankylosing spondylitis	4.15e-05	0.0233	CbGdCrCtD
Methotrexate—Anorexia—Prednisone—ankylosing spondylitis	4.14e-05	0.00051	CcSEcCtD
Methotrexate—Feeling abnormal—Betamethasone—ankylosing spondylitis	4.11e-05	0.000506	CcSEcCtD
Methotrexate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	4.11e-05	0.000506	CcSEcCtD
Methotrexate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	4.08e-05	0.000503	CcSEcCtD
Methotrexate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	4.08e-05	0.000503	CcSEcCtD
Methotrexate—TYMS—Danazol—Prednisone—ankylosing spondylitis	4.08e-05	0.0229	CbGdCrCtD
Methotrexate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	4.05e-05	0.000499	CcSEcCtD
Methotrexate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	4.04e-05	0.000498	CcSEcCtD
Methotrexate—Urticaria—Dexamethasone—ankylosing spondylitis	3.96e-05	0.000488	CcSEcCtD
Methotrexate—Urticaria—Betamethasone—ankylosing spondylitis	3.96e-05	0.000488	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	3.96e-05	0.000488	CcSEcCtD
Methotrexate—Dizziness—Prednisolone—ankylosing spondylitis	3.95e-05	0.000487	CcSEcCtD
Methotrexate—Asthenia—Triamcinolone—ankylosing spondylitis	3.94e-05	0.000486	CcSEcCtD
Methotrexate—Body temperature increased—Dexamethasone—ankylosing spondylitis	3.94e-05	0.000486	CcSEcCtD
Methotrexate—Abdominal pain—Betamethasone—ankylosing spondylitis	3.94e-05	0.000486	CcSEcCtD
Methotrexate—Abdominal pain—Dexamethasone—ankylosing spondylitis	3.94e-05	0.000486	CcSEcCtD
Methotrexate—Body temperature increased—Betamethasone—ankylosing spondylitis	3.94e-05	0.000486	CcSEcCtD
Methotrexate—Asthenia—Methylprednisolone—ankylosing spondylitis	3.93e-05	0.000485	CcSEcCtD
Methotrexate—Insomnia—Prednisone—ankylosing spondylitis	3.93e-05	0.000484	CcSEcCtD
Methotrexate—Paraesthesia—Prednisone—ankylosing spondylitis	3.9e-05	0.000481	CcSEcCtD
Methotrexate—Pruritus—Triamcinolone—ankylosing spondylitis	3.89e-05	0.000479	CcSEcCtD
Methotrexate—Pruritus—Methylprednisolone—ankylosing spondylitis	3.88e-05	0.000478	CcSEcCtD
Methotrexate—Dyspepsia—Prednisone—ankylosing spondylitis	3.82e-05	0.000471	CcSEcCtD
Methotrexate—Decreased appetite—Prednisone—ankylosing spondylitis	3.78e-05	0.000465	CcSEcCtD
Methotrexate—Rash—Prednisolone—ankylosing spondylitis	3.77e-05	0.000464	CcSEcCtD
Methotrexate—Dermatitis—Prednisolone—ankylosing spondylitis	3.76e-05	0.000464	CcSEcCtD
Methotrexate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	3.75e-05	0.000462	CcSEcCtD
Methotrexate—Fatigue—Prednisone—ankylosing spondylitis	3.74e-05	0.000461	CcSEcCtD
Methotrexate—Headache—Prednisolone—ankylosing spondylitis	3.74e-05	0.000461	CcSEcCtD
Methotrexate—Dizziness—Triamcinolone—ankylosing spondylitis	3.63e-05	0.000448	CcSEcCtD
Methotrexate—Dizziness—Methylprednisolone—ankylosing spondylitis	3.63e-05	0.000447	CcSEcCtD
Methotrexate—Feeling abnormal—Prednisone—ankylosing spondylitis	3.58e-05	0.000441	CcSEcCtD
Methotrexate—Asthenia—Dexamethasone—ankylosing spondylitis	3.58e-05	0.000441	CcSEcCtD
Methotrexate—Asthenia—Betamethasone—ankylosing spondylitis	3.58e-05	0.000441	CcSEcCtD
Methotrexate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	3.55e-05	0.000438	CcSEcCtD
Methotrexate—Nausea—Prednisolone—ankylosing spondylitis	3.55e-05	0.000438	CcSEcCtD
Methotrexate—Pruritus—Dexamethasone—ankylosing spondylitis	3.53e-05	0.000435	CcSEcCtD
Methotrexate—Pruritus—Betamethasone—ankylosing spondylitis	3.53e-05	0.000435	CcSEcCtD
Methotrexate—Vomiting—Triamcinolone—ankylosing spondylitis	3.49e-05	0.000431	CcSEcCtD
Methotrexate—Vomiting—Methylprednisolone—ankylosing spondylitis	3.49e-05	0.00043	CcSEcCtD
Methotrexate—Rash—Triamcinolone—ankylosing spondylitis	3.47e-05	0.000427	CcSEcCtD
Methotrexate—Dermatitis—Triamcinolone—ankylosing spondylitis	3.46e-05	0.000427	CcSEcCtD
Methotrexate—Rash—Methylprednisolone—ankylosing spondylitis	3.46e-05	0.000426	CcSEcCtD
Methotrexate—Dermatitis—Methylprednisolone—ankylosing spondylitis	3.45e-05	0.000426	CcSEcCtD
Methotrexate—Urticaria—Prednisone—ankylosing spondylitis	3.45e-05	0.000425	CcSEcCtD
Methotrexate—Headache—Triamcinolone—ankylosing spondylitis	3.44e-05	0.000424	CcSEcCtD
Methotrexate—Headache—Methylprednisolone—ankylosing spondylitis	3.44e-05	0.000423	CcSEcCtD
Methotrexate—Abdominal pain—Prednisone—ankylosing spondylitis	3.43e-05	0.000423	CcSEcCtD
Methotrexate—Body temperature increased—Prednisone—ankylosing spondylitis	3.43e-05	0.000423	CcSEcCtD
Methotrexate—Diarrhoea—Betamethasone—ankylosing spondylitis	3.41e-05	0.000421	CcSEcCtD
Methotrexate—Diarrhoea—Dexamethasone—ankylosing spondylitis	3.41e-05	0.000421	CcSEcCtD
Methotrexate—Dizziness—Betamethasone—ankylosing spondylitis	3.3e-05	0.000406	CcSEcCtD
Methotrexate—Dizziness—Dexamethasone—ankylosing spondylitis	3.3e-05	0.000406	CcSEcCtD
Methotrexate—Nausea—Triamcinolone—ankylosing spondylitis	3.26e-05	0.000402	CcSEcCtD
Methotrexate—Nausea—Methylprednisolone—ankylosing spondylitis	3.26e-05	0.000401	CcSEcCtD
Methotrexate—Hypersensitivity—Prednisone—ankylosing spondylitis	3.2e-05	0.000394	CcSEcCtD
Methotrexate—Vomiting—Betamethasone—ankylosing spondylitis	3.17e-05	0.000391	CcSEcCtD
Methotrexate—Vomiting—Dexamethasone—ankylosing spondylitis	3.17e-05	0.000391	CcSEcCtD
Methotrexate—Rash—Dexamethasone—ankylosing spondylitis	3.14e-05	0.000388	CcSEcCtD
Methotrexate—Rash—Betamethasone—ankylosing spondylitis	3.14e-05	0.000388	CcSEcCtD
Methotrexate—Dermatitis—Dexamethasone—ankylosing spondylitis	3.14e-05	0.000387	CcSEcCtD
Methotrexate—Dermatitis—Betamethasone—ankylosing spondylitis	3.14e-05	0.000387	CcSEcCtD
Methotrexate—Headache—Betamethasone—ankylosing spondylitis	3.12e-05	0.000385	CcSEcCtD
Methotrexate—Headache—Dexamethasone—ankylosing spondylitis	3.12e-05	0.000385	CcSEcCtD
Methotrexate—Asthenia—Prednisone—ankylosing spondylitis	3.12e-05	0.000384	CcSEcCtD
Methotrexate—Pruritus—Prednisone—ankylosing spondylitis	3.07e-05	0.000379	CcSEcCtD
Methotrexate—Diarrhoea—Prednisone—ankylosing spondylitis	2.97e-05	0.000366	CcSEcCtD
Methotrexate—Nausea—Betamethasone—ankylosing spondylitis	2.96e-05	0.000365	CcSEcCtD
Methotrexate—Nausea—Dexamethasone—ankylosing spondylitis	2.96e-05	0.000365	CcSEcCtD
Methotrexate—Dizziness—Prednisone—ankylosing spondylitis	2.87e-05	0.000354	CcSEcCtD
Methotrexate—Vomiting—Prednisone—ankylosing spondylitis	2.76e-05	0.00034	CcSEcCtD
Methotrexate—Rash—Prednisone—ankylosing spondylitis	2.74e-05	0.000337	CcSEcCtD
Methotrexate—Dermatitis—Prednisone—ankylosing spondylitis	2.74e-05	0.000337	CcSEcCtD
Methotrexate—Headache—Prednisone—ankylosing spondylitis	2.72e-05	0.000335	CcSEcCtD
Methotrexate—Nausea—Prednisone—ankylosing spondylitis	2.58e-05	0.000318	CcSEcCtD
